Exagen Inc. XGN Change in Accrued Liabilities
Change in Accrued Liabilities at other companies
Other financials
Where this comes from
Reported directly by Exagen Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities.
The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Exagen Inc.'s change in accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Exagen Inc.'s change in accrued liabilities?
- Exagen Inc. (XGN) reported change in accrued liabilities of -$1.56M in Q1 2026.
- How has Exagen Inc.'s change in accrued liabilities changed year-over-year?
- Exagen Inc.'s change in accrued liabilities decreased by 9.8% year-over-year, from -$1.42M to -$1.56M.
- What is the long-term trend for Exagen Inc.'s change in accrued liabilities?
- Over 2 years (2021 to 2025), Exagen Inc.'s change in accrued liabilities has grown at a -49.5% compound annual growth rate (CAGR), from $984K to $251K.
- What does change in accrued liabilities mean?
- Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.